Q: What is Ranexa used for?

Ranexa is used to treat chronic angina .

Q: How does Ranexa work?

Mechanism of Action The exact way Ranexa works to treat chronic chest pain (angina) is not fully understood. However, medical research suggests it works by affecting the flow of certain minerals, specifically sodium and calcium, into the heart's muscle cells. In people with chronic angina, an excess of sodium can enter the heart cells, which leads to a buildup of calcium. This buildup can cause the heart muscle to remain tense and prevent it from relaxing properly between beats. Ranexa is believed to help by: Inhibiting the late inward sodium current in the heart cells. Reducing the accumulation of calcium in the heart muscle. Helping the heart muscle relax more effectively. Improving blood flow to the heart. How It Differs From Other Treatments Unlike many other medications used for chest pain, such as beta-blockers or calcium channel blockers, Ranexa does not significantly lower your heart rate or blood pressure. It is intended for the long-term management of chronic angina symptoms and is not used to treat a sudden, acute attack of chest pain.

Q: What are the active ingredients in Ranexa?

The active ingredient in Ranexa is ranolazine .

Q: What are the side effects of Ranexa?

Common side effects of Ranexa may include: dizziness headache constipation and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Ranexa?

Ranexa belongs to the antianginal agent drug class.

Q: What is the dosage of Ranexa and how do I take it?

How to Take Ranexa Ranexa is taken by mouth as an extended-release tablet. It is usually prescribed to be taken twice daily. You may take this medication with or without food. To help you remember your doses, try to take the medication at the same times each day. When taking this medication, follow these instructions: Swallow the tablets whole. Do not crush, chew, or break the tablets, as this can interfere with the extended-release mechanism and release the drug too quickly. Missed Dose If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take extra medicine or two doses at the same time to make up for a missed dose.

Q: Is Ranexa safe during pregnancy and breastfeeding?

Pregnancy There is limited information regarding the use of Ranexa in pregnant women. While animal studies did not show significant harm to the fetus at typical doses, these results do not always predict human response. This medication should only be used during pregnancy if a healthcare provider determines that the potential benefits outweigh the potential risks to the unborn baby. Breastfeeding It is not known if Ranexa passes into human breast milk. Because many medications are excreted in milk and there is a potential for serious side effects in a nursing infant, healthcare providers typically advise choosing between breastfeeding or taking Ranexa. It is important to discuss your options with a clinician to ensure the safety of the infant.

Q: What is the FDA approval status of Ranexa?

FDA Approval and Indications Ranexa (ranolazine) received FDA approval in 2006. It is indicated for the treatment of chronic angina. It may be used as a standalone treatment or in combination with other cardiovascular medications such as beta-blockers, nitrates, calcium channel blockers, antiplatelet therapy, and lipid-lowering therapy. Safety Communications and Restrictions The FDA has issued safety communications regarding potential drug interactions. Specifically, there are dose limitations for certain cholesterol-lowering medications; patients taking Ranexa should not exceed 20 mg of simvastatin daily due to an increased risk of muscle toxicity ( myopathy ). Contraindications Regulatory labeling specifies that Ranexa is contraindicated in patients with clinically significant liver cirrhosis. It is also contraindicated for use with strong CYP3A inhibitors, such as certain antifungals and antibiotics, and strong CYP3A inducers, such as rifampin or St. John's wort, as these can significantly alter the levels of the drug in the bloodstream. Monitoring and Safety Signals While Ranexa does not have a boxed warning, the FDA has monitored potential safety signals through the Adverse Event Reporting System (FAERS), including evaluations for drug-induced liver injury. Healthcare providers are advised to monitor kidney function in patients with severe renal impairment and to assess for potential heart rhythm changes, such as QT prolongation, which is a known risk associated with the medication.

Question 1

What is Ranexa?

Accepted Answer

Ranexa is an antianginal medication that contains the active ingredient ranolazine. It is used to help manage symptoms of heart-related chest pain by improving how the heart functions under stress. The medication works by affecting specific electrical and metabolic processes within the heart muscle cells.

This medication is designed for the long-term management of symptoms rather than for the immediate relief of sudden chest pain. It assists in the ongoing management of heart-related discomfort by helping the heart use oxygen more effectively.

Question 2

What is Ranexa used for?

Accepted Answer

Ranexa is used to treat chronic angina.

Question 3

How does Ranexa work?

Accepted Answer

Mechanism of Action

The exact way Ranexa works to treat chronic chest pain (angina) is not fully understood. However, medical research suggests it works by affecting the flow of certain minerals, specifically sodium and calcium, into the heart's muscle cells.

In people with chronic angina, an excess of sodium can enter the heart cells, which leads to a buildup of calcium. This buildup can cause the heart muscle to remain tense and prevent it from relaxing properly between beats. Ranexa is believed to help by:

Inhibiting the late inward sodium current in the heart cells.
Reducing the accumulation of calcium in the heart muscle.
Helping the heart muscle relax more effectively.
Improving blood flow to the heart.

How It Differs From Other Treatments

Unlike many other medications used for chest pain, such as beta-blockers or calcium channel blockers, Ranexa does not significantly lower your heart rate or blood pressure. It is intended for the long-term management of chronic angina symptoms and is not used to treat a sudden, acute attack of chest pain.

Question 4

What are the active ingredients in Ranexa?

Accepted Answer

The active ingredient in Ranexa is ranolazine.

Question 5

What are the side effects of Ranexa?

Accepted Answer

Common side effects of Ranexa may include:

dizziness
headache
constipation
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Ranexa?

Accepted Answer

Ranexa belongs to the antianginal agent drug class.

Question 7

What is the dosage of Ranexa and how do I take it?

Accepted Answer

How to Take Ranexa

Ranexa is taken by mouth as an extended-release tablet. It is usually prescribed to be taken twice daily. You may take this medication with or without food. To help you remember your doses, try to take the medication at the same times each day.

When taking this medication, follow these instructions:

Swallow the tablets whole.
Do not crush, chew, or break the tablets, as this can interfere with the extended-release mechanism and release the drug too quickly.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take extra medicine or two doses at the same time to make up for a missed dose.

Question 8

Is Ranexa safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the use of Ranexa in pregnant women. While animal studies did not show significant harm to the fetus at typical doses, these results do not always predict human response. This medication should only be used during pregnancy if a healthcare provider determines that the potential benefits outweigh the potential risks to the unborn baby.

Breastfeeding

It is not known if Ranexa passes into human breast milk. Because many medications are excreted in milk and there is a potential for serious side effects in a nursing infant, healthcare providers typically advise choosing between breastfeeding or taking Ranexa. It is important to discuss your options with a clinician to ensure the safety of the infant.

Question 9

What forms and strengths does Ranexa come in?

Accepted Answer

Ranexa is supplied as a tablet for oral administration. These tablets are designed for extended release, which means the active ingredient is released into the bloodstream slowly over time.

The tablets are film-coated and should be swallowed whole. Breaking, crushing, or chewing the tablets can cause too much of the drug to be released at once.

Question 10

What is the FDA approval status of Ranexa?

Accepted Answer

FDA Approval and Indications

Ranexa (ranolazine) received FDA approval in 2006. It is indicated for the treatment of chronic angina. It may be used as a standalone treatment or in combination with other cardiovascular medications such as beta-blockers, nitrates, calcium channel blockers, antiplatelet therapy, and lipid-lowering therapy.

Safety Communications and Restrictions

The FDA has issued safety communications regarding potential drug interactions. Specifically, there are dose limitations for certain cholesterol-lowering medications; patients taking Ranexa should not exceed 20 mg of simvastatin daily due to an increased risk of muscle toxicity (myopathy).

Contraindications

Regulatory labeling specifies that Ranexa is contraindicated in patients with clinically significant liver cirrhosis. It is also contraindicated for use with strong CYP3A inhibitors, such as certain antifungals and antibiotics, and strong CYP3A inducers, such as rifampin or St. John's wort, as these can significantly alter the levels of the drug in the bloodstream.

Monitoring and Safety Signals

While Ranexa does not have a boxed warning, the FDA has monitored potential safety signals through the Adverse Event Reporting System (FAERS), including evaluations for drug-induced liver injury. Healthcare providers are advised to monitor kidney function in patients with severe renal impairment and to assess for potential heart rhythm changes, such as QT prolongation, which is a known risk associated with the medication.

Question 11

What should I know about Ranexa and cost?

Accepted Answer

Generic Availability

Ranexa is available as a generic medication called ranolazine. Generic drugs are typically much less expensive than brand-name versions while containing the same active ingredients and providing the same effects.

Insurance and Medicare Coverage

Many insurance plans and Medicare Part D cover the generic form of ranolazine. The actual amount you pay will vary based on your plan's list of covered drugs, your specific copay, and whether you have met your annual deductible.

Pharmacy and Prescription Factors

Several other factors can influence the price of this medication:

Pharmacy Choice: Prices can differ between retail chain pharmacies, independent pharmacies, and mail-order services.
Dosage Strength: Ranexa is available in 500 mg and 1000 mg extended-release tablets. The strength and the total number of tablets in the prescription will affect the final price.

If you have difficulty paying for your medication, you may want to speak with your healthcare provider or pharmacist about potential savings options or financial assistance programs.

Ranexa

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Ranexa

Hospitals.net Disclosure